Select for export Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881119897615 PubMed 31916890 Copy citation Copy BibTeX Journal of Psychopharmacology 2020-01-08 Gabrielle Agin-Liebes, Tara C. Malone, Matthew M. Yalch, Sarah E. Mennenga, Katherine Ponte, Jeffrey Guss OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export The psychedelic renaissance: the next trip for psychiatry? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/ipm.2019.39 PubMed 31543078 Copy citation Copy BibTeX Unknown journal 2019-09-22 Kelly JR, Baker A, Babiker M, Burke L, Brennan C, O'Keane V. Europe PMC Published psilocybin DepressionAnxietyNeuroplasticity Randomized Controlled Trial More
Select for export The Potential of Psilocybin Administration in Terminal Cancer Patients Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/01.cot.0000574916.46844.cf Copy citation Copy BibTeX Oncology Times 2019-06-27 Richard Simoneaux OpenAlex Published psilocybinpsilocin DepressionAnxietyAddiction Clinical Trial More
Select for export Psilocybin-Assisted Therapy: A Double-Blind Randomized Controlled Trial No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Unknown journal 2018-12-31 Katherine Gruppo OpenAlex Published psilocybin Randomized Controlled Trial Randomized Controlled Trial More
Select for export Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/17512433.2018.1511424 PubMed 30102078 Copy citation Copy BibTeX Unknown journal 2018-08-22 Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC. Europe PMC Published psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Are psychedelics effective in treating anxiety associated with a lifethreatening disease Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine) 2017-12-31 Kayla Wilwohl OpenAlex Published psilocybin AnxietyEnd-of-Life DistressReceptor Pharmacology Randomized Controlled Trial More
Select for export Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pnpbp.2017.09.012 PubMed 28947181 Copy citation Copy BibTeX Unknown journal 2017-09-21 Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T. Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experience No abstract availability was recorded for this entry. Details DOI 10.1016/j.drugalcdep.2016.08.058 Copy citation Copy BibTeX Drug and Alcohol Dependence 2017-01-20 Frederick S. Barrett, Matthew W. Johnson, Roland R. Griffiths OpenAlex Published psilocybin AddictionDefault Mode NetworkRandomized Controlled Trial Randomized Controlled Trial More
Select for export Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116675512 PubMed 27909164 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-11-30 Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot study No abstract availability was recorded for this entry. Details DOI 10.1016/j.drugalcdep.2014.02.200 Copy citation Copy BibTeX Drug and Alcohol Dependence 2014-06-06 Albert Garcia-Romeu, Matthew W. Johnson, Roland R. Griffiths OpenAlex Published psilocybin AddictionMechanism of ActionRandomized Controlled Trial Randomized Controlled Trial More
Select for export A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3109/00952990.2013.811513 PubMed 23968172 Copy citation Copy BibTeX The American Journal of Drug and Alcohol Abuse 2013-08-31 Burdick BV, Adinoff B. Europe PMC Published psilocybin AddictionMystical ExperienceClinical Trial Randomized Controlled Trial More
Select for export Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0014074 PubMed 21152030 Copy citation Copy BibTeX PLoS ONE 2010-12-01 Matthew J. Baggott, Jennifer D. Siegrist, Gantt P. Galloway, Lynn C. Robertson, Jeremy Coyle, John Mendelson OpenAlex Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Randomized Controlled Trial More
